Tolerogenic plasmacytoid DC

Plasmacytoid DC (pDC) are type-I IFN-producing cells known for their capacity to promote anti-viral innate and adaptive immune responses. Despite their potent anti-viral function, when compared with conventional DC, pDC exhibit poor immunostimulatory ability and their interaction with T cells often...

Full description

Saved in:
Bibliographic Details
Published in:European journal of immunology 2010-10, Vol.40 (10), p.2667-2676
Main Authors: Matta, Benjamin M, Castellaneta, Antonino, Thomson, Angus W
Format: Article
Language:English
Subjects:
Animals
Dendritic Cells - immunology
Humans
Immune Tolerance - immunology
Immunity, Mucosal - immunology
Mice
Plasmacytoid DC
T-Lymphocytes, Regulatory - immunology
Tolerance
Toll-Like Receptors - immunology
Treg
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Plasmacytoid DC (pDC) are type-I IFN-producing cells known for their capacity to promote anti-viral innate and adaptive immune responses. Despite their potent anti-viral function, when compared with conventional DC, pDC exhibit poor immunostimulatory ability and their interaction with T cells often favors the generation of Treg. pDC are activated primarily in response to ssRNA and ssDNA through TLR7 and TLR9, respectively, but also through TLR-independent mechanisms. Non-lymphoid tissue pDC, such as those residing in the airways, gut, and liver, play a significant role in regulating mucosal immunity and are critical for the development of tolerance to inhaled or ingested antigens. Herein we discuss properties that define tolerogenic pDC and how their unique characteristics translate into an ability to regulate immunity and promote the development of tolerance. We cover the importance of pDC during intrathymic Treg development and the maintenance of peripheral tolerance, as well as their regulatory role in transplantation, autoimmunity, and cancer. We highlight recent findings regarding danger-associated molecular pattern and PAMP signaling in the regulation of pDC function, and how the ability of pDC to promote tolerance translates into the potential clinical applications of these cells as therapeutic targets to regulate immune reactivity.
ISSN:0014-2980
1521-4141
DOI:10.1002/eji.201040839